Carolina Colli Cruz
0000-0001-7065-3769
Publication & Citation Trends
Publications
0 total
Efficacy of current therapeutic strategies for immune checkpoint inhibitor-related esophagitis
Cited by 0
Semantic Scholar
Sa1826: THE PROGNOSTIC VALUE OF FECAL CALPROTECTIN IN PREDICTING NEED FOR AGGRESSIVE TREATMENT AND FUTURE DISEASE REMISSION AMONG PATIENTS WITH IMMUNE CHECKPOINT INHIBITOR COLITIS
Cited by 1
Semantic Scholar
Mo1886: SURVIVAL OUTCOMES IN PATIENTS WITH CANCER AND INFLAMMATORY BOWEL DISEASE: FACTORS INFLUENCING MORTALITY
Cited by 0
Semantic Scholar
Sa1941: EFFICACY OF BEZLOTOXUMAB FOR PREVENTING RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION IN PATIENTS WITH CANCER
Cited by 0
Semantic Scholar
Tu1789: EVALUATION OF THERAPEUTIC STRATEGIES FOR IMMUNE-MEDIATED ESOPHAGITIS IN CANCER PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS
Cited by 0
Semantic Scholar
Gastrointestinal Infection Before Immune Checkpoint Inhibition Hinders Treatment Efficacy and Increases the Risk of Colitis
Cited by 1
Semantic Scholar
S347 Pan-Gastrointestinal Immune-Related Adverse Events: Characterization and Outcomes
Cited by 0
Semantic Scholar
Tu1778: FECAL TRANSPLANTATION IMPROVED PATIENTS’ REPORTED OUTCOME AFTER IMMUNE CHECKPOINT INHIBITOR COLITIS
Cited by 1
Semantic Scholar
Research Topics
CAR-T cell therapy research
(82)
Immune Cell Function and Interaction
(71)
Cytomegalovirus and herpesvirus research
(49)
Virus-based gene therapy research
(34)
Immunotherapy and Immune Responses
(32)
Affiliations
George Washington University Hospital
Houston Methodist
Children's National
The University of Texas MD Anderson Cancer Center
Baylor College of Medicine